Donnowitz Kathrine, Rush Jordan, Webb Megan, Hogan Samantha, Mann Jami, Reichard Jeffrey, Ginn Mary Beth, O'Bryan Laurie, Lyons Mark, Barzin Amir H
J Am Pharm Assoc (2003). 2023 Sep-Oct;63(5):1623-1627. doi: 10.1016/j.japh.2023.06.018. Epub 2023 Jun 29.
During the evolution of the COVID-19 pandemic, health care entities had to adapt to rapidly changing research and best practices in disease prevention and treatment to maintain the delivery of high-quality patient care. Prompt interdisciplinary efforts amongst physician, pharmacist, nursing, and information technology teammates are needed to develop robust centralized strategies to allocate and administer COVID-19 therapies in the ambulatory setting.
The objective of this analysis is to demonstrate the impact of a system-wide, centralized workflow on referral times and treatment outcomes for COVID-19 infected patients in the ambulatory setting.
Upon release of monoclonal antibodies for the treatment of COVID-19, a centralized approach for patient treatment referrals to the University of North Carolina Health Virtual Practice team was developed due to the limited supply. Collaboration with infectious disease colleagues played a pivotal role in the rapid application of therapeutic guidance and creation of treatment prioritization levels.
From November 2020 through February 2022, the centralized workflow team facilitated the administration of over 17,000 COVID-19 treatment infusions. The median time from treatment referral to infusion was 2 days from a positive COVID-19 test result. From January through February 2022, 514 oral COVID-19 treatment courses were dispensed from the health system's outpatient pharmacies. The median time from referral to treatment was 1 day from diagnosis.
Given the ongoing strain and demand of COVID-19 on the health care system, a centralized, multidisciplinary team of experts allowed for efficient delivery of COVID-19 therapies through one provider touchpoint. The collaboration between outpatient pharmacies, infusion sites, and Virtual Practice culminated in a sustainable, centralized treatment approach that supported widespread reach, and equitable dose distribution, to the most vulnerable patient populations.
在新冠疫情演变过程中，医疗保健机构必须适应疾病预防和治疗方面迅速变化的研究及最佳实践，以维持高质量的患者护理服务。需要医生、药剂师、护士和信息技术团队成员迅速开展跨学科协作，制定强有力的集中策略，以便在门诊环境中分配和管理新冠治疗方法。
本分析的目的是证明全系统集中式工作流程对门诊环境中新冠感染患者的转诊时间和治疗结果的影响。
由于单克隆抗体治疗新冠的药物供应有限，在其发布后，北卡罗来纳大学健康虚拟实践团队制定了一种集中式患者治疗转诊方法。与传染病同事的合作在迅速应用治疗指南和创建治疗优先级方面发挥了关键作用。
从2020年11月到2022年2月，集中式工作流程团队协助管理了超过17000次新冠治疗输液。从新冠检测呈阳性结果到治疗转诊再到输液的中位时间为2天。在2022年1月至2月期间，从该医疗系统的门诊药房分发了514个口服新冠治疗疗程。从转诊到治疗的中位时间为确诊后1天。
鉴于新冠疫情对医疗保健系统持续造成的压力和需求，一个集中的多学科专家团队能够通过一个提供者接触点高效地提供新冠治疗方法。门诊药房、输液点和虚拟实践之间的合作最终形成了一种可持续的集中治疗方法，该方法支持广泛覆盖，并为最脆弱的患者群体公平分配剂量。
